Group 1 - Aolide plans to raise no more than 300 million yuan through a simplified procedure for issuing shares to specific targets, with net proceeds allocated to the production base project for OLED display core materials and to supplement working capital [1] - Wanbang's subsidiary has obtained a 10-year exclusive agency for sildenafil oral suspension, which is suitable for patients with swallowing difficulties [2] - Titan Technology and its affiliate plan to jointly invest in increasing capital for its subsidiary, Micro Detection, raising its registered capital from 10 million yuan to 50 million yuan [3] Group 2 - Jindike will not issue new batches of quadrivalent influenza virus split vaccine this year, having produced approximately 1.56 million doses [4] - Aladdin intends to purchase 35% equity of Youke for 61.25 million yuan, funded by its own or raised capital [5] - Gujia Home's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] Group 3 - Honghe Technology's application for a private placement of A-shares has been approved by the China Securities Regulatory Commission [9] - Guangdian Yuntong has won contracts totaling 308 million yuan for the construction of an artificial intelligence application pilot base [10] - Shanghai Mechanical plans to repurchase B-shares worth no more than 278 million yuan [11] Group 4 - Weiling Co. is planning a change of control, with shares representing 7.76% of the total being transferred [14] - Jiugang Hongxing intends to invest 200 million yuan to establish a wholly-owned subsidiary focusing on high-quality special steel materials [16] - Zhongjian Technology has submitted an application for H-share listing [17] Group 5 - Sainuo Medical has received registration approval for its coronary product in Pakistan [18] - Huafeng Aluminum plans to acquire 100% equity of Huafeng Puen for 100 million yuan [20] - Fuda Co. intends to establish a wholly-owned subsidiary with an investment of 30 million yuan [22] Group 6 - Su Yan Jingshen's application for a private placement of shares has been approved by the Shanghai Stock Exchange [24] - Zhongchuang Co. has set the inquiry transfer price at 25.75 yuan per share [25] - Jinpu Garden has had a lawsuit involving 26.557 million yuan accepted by the court [29] Group 7 - ICBC has approved the appointment of Zhao Guid as vice president [30] - Betta Pharmaceuticals has had its drug registration application for ensartinib accepted [32] - Times New Materials plans to invest 6 million euros to establish a wholly-owned subsidiary in Serbia [34] Group 8 - China State Construction has appointed Chen Yong as vice president [36] - Dayang Electric plans to invest 10 million yuan to establish an industrial fund [38] - Advanced Digital has appointed Liu Zhigang as deputy general manager [39] Group 9 - Tianqi Co. plans to transfer 7% equity of Youqi Intelligent for 130 million yuan [40] - Xinguo has submitted an application for H-share issuance and listing [42] - Jinhongshun's shareholder has terminated a share reduction plan [43] Group 10 - Wanrun Co.'s actual controller plans to increase shareholding between 365 million yuan and 730 million yuan [44] - Suzhou High-tech plans to sell 47% equity of its medical device subsidiary for 604 million yuan [45] - Huayou Cobalt's subsidiary has signed a product supply agreement with Yiwei Lithium Energy for approximately 127,800 tons of materials [47] Group 11 - China Communications has won 10 important projects totaling approximately 2.539 billion yuan [49] - Nopushin plans to raise no more than 1.45 billion yuan through a private placement [50] - Yun Aluminum plans to acquire minority stakes in three subsidiaries for a total of 2.267 billion yuan [51] Group 12 - Xiamen Tungsten plans to establish a 500 million yuan merger fund with multiple parties [52] - Aotewei has signed a contract worth approximately 700 million yuan [54] - Hemai Co.'s shareholders plan to reduce their holdings by no more than 3% [56]

苏盐井神公告，公司于2025年11月26日收到上海证券交易所出具的《关于江苏苏盐井神股份有限公司向 特定对象发行股票的交易所审核意见》，认为公司向特定对象发行股票申请符合发行条件、上市条件和 信息披露要求。公司本次向特定对象发行A股股票事项尚需中国证券监督管理委员会同意注册后方可实 施，最终能否获得中国证监会同意注册的决定及其时间尚存在不确定性。 ...

Core Viewpoint - The company has received approval from the Shanghai Stock Exchange for its application to issue A-shares to specific investors, pending final approval from the China Securities Regulatory Commission (CSRC) [1] Group 1 - The company received the review opinion from the Shanghai Stock Exchange on November 26, 2025, confirming that the application meets the issuance and listing conditions as well as information disclosure requirements [1] - The issuance of A-shares to specific investors is subject to the CSRC's approval, and the timing and outcome of this approval remain uncertain [1] - The company will fulfill its information disclosure obligations based on the progress of this matter, urging investors to be aware of investment risks [1]

格隆汇11月26日丨江盐集团(601065.SH)在投资者互动平台表示，钠离子电池原料工作已开展前期调 研，相关工作正在推进过程中。 ...

格隆汇11月26日丨江盐集团(601065.SH)在投资者互动平台表示，现阶段公司卤水提锂项目顺利投产后 预计可年产200吨碳酸锂，未来产能规划将根据市场需求来确定。 ...

雪天盐业在坚守品质的同时，持续加快高端化、差异化和特色化产品战略。公司建成全国首条井矿盐零 添加独立生产线，创新推出纯度高达99.7%的"松態997"生态系列产品，荣获全国首张"生态井矿盐"认证 证书。近两年，公司推出生态盐、海藻碘低钠盐、三餐四季等系列产品，覆盖家庭全场景健康用盐。此 外，公司还通过生成式AI技术推出品牌智能体——"盐知晓"，夯实"健康用盐方案解决者"行业定位。 2024年盐产品毛利率提升1.14%，2025年前10个月中高端盐销售占比接近15%，品牌价值达184.99亿 元。 在培育新增长动能上，公司前瞻布局新质生产力。衡阳绿色低碳盐碱产业园构建"盐－盐化工－新材 料"一体化链条，参股子公司美特新材联合共建钠电研究院攻克关键技术，5000吨锂电正极材料智能生 产线建成投产。2025年7月，与复旦大学团队共建未来纤维研究院，拓展盐资源高附加值利用新路径。 通过前瞻性布局新产业领域，雪天盐业正积极开辟第二增长曲线，以驱动公司的未来增长。 截至目前，雪天盐业通过深化改革实现治理效能跃升，降本创效超3.6亿元，精益管理推动主产品综合 能耗较上年下降2.15%，减少二氧化碳排放量5.4万吨。这一系列 ...

转自：新华财经 第八届湖南省省长质量奖的奖杯花落雪天盐业。这份湖南质量领域的最高荣誉，不仅是对其数十年品质 坚守的加冕，更剖开一则"逆势破局"的生存样本：当下行周期压顶，这家湖南省属国企用极致降本筑牢 基本盘、逆势加码布局"新"项目，走出一条"提质增效、强身健体"高质量发展之路。 节流增效 厚植抗周期发展底气 雪天盐业贯彻极致降本理念，集团层面率先垂范，从精简会议开支、压缩差旅标准到严控非生产性支 出。今年1—9月，集团非生产性支出较去年同期下降45.07%。基层一线则掀起"金点子"热潮，员工围绕 生产工艺优化、能耗管控等提出改善建议近500条，采纳实施率达76%。从技术骨干到普通员工，雪天 盐业以"全员冲锋"的姿态，把降本潜力挖到极致，让每一分节约都转化为穿越寒冬的底气。 精益管理 擦亮质量管控金名片 作为"中国盐改第一股"，雪天盐业坚定市场化改革，实施高端品牌战略，以科技创新驱动产品升级。公 司建成全国首条井矿盐零添加独立生产线，创新推出纯度高达99.7%的"松態997"生态系列产品，纯度远 超国家优级标准，荣获全国首张"生态井矿盐"认证证书，树立行业品质新标杆。 图为雪天 雪天盐业以卓越绩效模式为框架， ...

Group 1 - The core point of the news is that Zhongyan Chemical's stock price dropped by 5.1% to 8.37 CNY per share, with a trading volume of 249 million CNY and a turnover rate of 1.99%, resulting in a total market capitalization of 12.273 billion CNY [1] - Zhongyan Chemical, established on December 31, 1998, and listed on December 22, 2000, is located in Alashan, Inner Mongolia, and primarily engages in salt chemical business, with main products including sodium metal and soda ash [1] - The revenue composition of Zhongyan Chemical includes soda ash and its by-products at 50.75%, resin products at 27.76%, sodium products at 9.72%, chlor-alkali products at 9.19%, and other categories [1] Group 2 - From the perspective of major circulating shareholders, Southern Fund's Southern CSI 1000 ETF (512100) reduced its holdings by 137,500 shares in the third quarter, now holding 8.0469 million shares, which accounts for 0.55% of circulating shares [2] - The estimated floating loss for Southern CSI 1000 ETF today is approximately 3.6211 million CNY [2] - Southern CSI 1000 ETF, established on September 29, 2016, has a latest scale of 76.63 billion CNY, with a year-to-date return of 24.71% and a one-year return of 18.97% [2]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 责任编辑：小浪快报 第1笔成交价格为7.87元，成交114.34万股，成交金额899.86万元，溢价率为-10.67%，买方营业部为中 信证券股份有限公司赣州登峰大道证券营业部，卖方营业部为东吴证券股份有限公司上海西藏南路证券 营业部。 进一步统计，近3个月内该股累计发生4笔大宗交易，合计成交金额为3599.33万元。该股近5个交易日累 计下跌0.56%，主力资金合计净流出2716.89万元。 11月19日，江盐集团收涨0.80%，收盘价为8.81元，发生1笔大宗交易，合计成交量114.34万股，成交金 额899.86万元。 ...

Core Viewpoint - Yaxing Chemical (600319) has announced a major asset restructuring plan to acquire 100% equity of Shandong Tianyi Chemical Co., Ltd. through a combination of share issuance and cash payment, aiming to deepen its presence in the salt chemical sector and enhance its product matrix [1][2] Group 1: Acquisition Details - The acquisition involves issuing shares at a price of 5.83 yuan per share, based on 80% of the average trading price over the previous 120 trading days [2] - The company will also raise supporting funds to cover cash payments, transaction taxes, integration costs, and to enhance liquidity for both the listed company and the target asset [2] - Upon completion, Tianyi Chemical will become a wholly-owned subsidiary of Yaxing Chemical, with the controlling shareholder remaining as Weifang City Investment Group [2] Group 2: Tianyi Chemical's Strengths - Tianyi Chemical is recognized as a "hidden champion" in the brominated flame retardant sector, holding over 50% market share in China [3] - The company has established strong technical barriers in its membrane materials business, contributing to national supply chain security [3] - Tianyi Chemical's financials show robust revenue and profit projections, with expected revenues of 1.283 billion yuan in 2023 and net profits of 54 million yuan [3] Group 3: Strategic Development Framework - Yaxing Chemical aims to build a multi-polar development framework focusing on "chlor-alkali + PVDC new materials + brominated flame retardants," enhancing business synergy and risk diversification [4][5] - The company is currently in a capacity recovery phase following a relocation of its production facilities, and the acquisition is seen as a strategic move to optimize operations and achieve growth [4][5] Group 4: Future Growth Potential - Yaxing Chemical's new projects, including a 45,000-ton high-end new materials (PVDC) project, are expected to enhance its sustainable development capabilities [6] - The restructuring is positioned as a strategic layout during a critical transformation period for the traditional chemical industry, aimed at improving operational strength and opening up growth opportunities [6]